A Comparison of Efficacy between Rebamipide and Omeprazole in the Treatment of NSAIDs Gastropathy

Authors

  • Suyata Suyata
  • Erita Bustami
  • Syadra Bardiman
  • Fuad Bakry

DOI:

https://doi.org/10.24871/53200489-94

Abstract

Background: Gastropathy represent a disparity of gastric mucosal characterized by sub-epithelial bleeding and erosion. Gastropathy can be induced by non steroidal anti-inflammatory drugs (NSAIDs), alcohol, stressor, and chemical agents with various sign and symptoms. NSAIDs-induced gastropathy is the second most common etiology of gastric ulcer and variceal haemorrhages. Aims: To investigate the effectivity of rebamipide compare with omeprazole in treatment of NSAIDs- induced gastropathy.
Method: This triple blind randomized study was enrolled from January to June 2004 with 38 subjects who were recruited from outpatient and inpatient clinic in M Hoesin Hospital in Palembang. Subject was divided into two groups. Endoscopic examination was performed in every patients.
Results: There was an improvement of symptom in rebamipide group (78.9%) and omeprazole group (79.0%) after treatment but it didn’t have significant difference statistically. Improvement of NSAIDs induced gastropathy after treatment between two groups have significant difference (P = 0.02), and improvement of gradation of gastropathy after treatment has significant difference (P = 0.007).There was no side effect of administration of rebamipide and omeprazole in each group.
Conclusion: Rebamipide as effective as omeprazole in improvement of symptom. Omeprazole is more effective than rebamipide in improvement of NSAIDs induced gastropathy and is as safe as rebamipide in the treatment of NSAIDs induced gastropathy.
Keywords: Gastropathy, NSAIDs, rebamipide, omeprazole
VOLUME 5, ISSUE 3, December 2004

Downloads

Published

2004-01-12

How to Cite

Suyata, S., Bustami, E., Bardiman, S., & Bakry, F. (2004). A Comparison of Efficacy between Rebamipide and Omeprazole in the Treatment of NSAIDs Gastropathy. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 5(3), 89–94. https://doi.org/10.24871/53200489-94

Issue

VOLUME 5, ISSUE 3, December 2004

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).